Search Results - "Benesova, K"

OC04.01: Prediction of non‐resectability in ovarian cancer patients using peritoneal cancer index: a prospective multicentre study using imaging (ISAAC study) by Pinto, P., Moro, F., Chiappa, V., Testa, A.C., Franchi, D., Alcazar, J., Frühauf, F., Burgetova, A., Mašek, M., Lambert, L., Altmanova, D., Arraiza, M., Avesani, G., Panico, C., Alessi, S., Pricolo, P., Vigorito, R., Calareso, G., Kocian, R., Slama, J., Urbinati, A.M. Vidal, Fagotti, A., Scambia, G., Raspagliesi, F., Cibula, D., Benesova, K., Jarkovsky, J., Fischerová, D.

Get full text

OC04.03: Preoperative assessment of non‐resectability in ovarian cancer according to ESGO criteria: a prospective multicentre study using imaging (ISAAC study) by Moro, F., Pinto, P., Chiappa, V., Testa, A., Alcazar, J., Franchi, D., Frühauf, F., Burgetova, A., Mašek, M., Lambert, L., Arraiza, M., Altmanova, D., Avesani, G., Panico, C., Alessi, S., Pricolo, P., Vigorito, R., Calareso, G., Kocian, R., Slama, J., Urbinati, A.M. Vidal, Fagotti, A., Scambia, G., Raspagliesi, F., Cibula, D., Benesova, K., Jarkovsky, J., Fischerová, D.

Get full text

OC04.02: Prediction of non‐resectability in ovarian cancer using the predictive index value score: a prospective multicentre study using imaging (ISAAC study) by Moro, F., Pinto, P., Chiappa, V., Testa, A., Alcazar, J., Franchi, D., Frühauf, F., Burgetova, A., Mašek, M., Lambert, L., Arraiza, M., Altmanova, D., Avesani, G., Panico, C., Alessi, S., Pricolo, P., Vigorito, R., Calareso, G., Roman, K., Slama, J., Urbinati, A.M. Vidal, Fagotti, A., Scambia, G., Raspagliesi, F., Cibula, D., Benesova, K., Jarkovsky, J., Fischerová, D.

Get full text

Further development of regional early care-Many roads lead to Rome : Developmental stages of four established rheumatological early care concepts in different regions of Germany by Benesova, K, Hansen, O, Sander, O, Feuchtenberger, M, Nigg, A, Voigt, A, Seipelt, E, Schneider, M, Lorenz, H-M, Krause, A

“…In order to shorten the prognostically relevant waiting time until diagnosis and initiation of appropriate treatment in inflammatory rheumatic diseases,…”
Get full text

How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors by Jordan, B., Benesova, K., Hassel, J.C., Wick, W., Jordan, K.

“…Immune-related neuromuscular adverse events are rare, but potentially life-threatening side-effects of immune checkpoint inhibitors (ICIs). They usually arise…”
Get full text

IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE SCREENING TEST FOR PRIMARY ALDOSTERONISM? by Václavík, J, Kristkova, M, Oprsalova, T, Jarkovsky, J, Benesova, K, Kociánová, E, Kamasová, M, Jelínek, L

“…OBJECTIVE:Primary hyperaldosteronism (PHA) is one of the most common causes of secondary hypertension. The aim of this work was to evaluate whether…”
Get full text

ADHERENCE TO ANTIHYPERTENSIVE MEDICATION AND LEFT VENTRICULAR HYPERTROPHY IN RESISTANT ARTERIAL HYPERTENSION by Kamasova, M, Vaclavik, J, Vaclavik, T, Kocianova, E, Jarkovsky, J, Benesova, K, Jelinek, L, Taborsky, M

“…OBJECTIVE:According to current registry data, 37% of hypertensive patients reach target blood pressure level. The failure to achieve target blood pressure…”
Get full text

Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL) by Janikova, A., Michalka, J., Chloupkova, R., Kopalova, N., Campr, V., Kamaradova, K., Kren, L., Belada, D., Benesova, K., Dlouha, J., Klener, P., Procházka, V., Mocikova, H., Duras, J., Trneny, M.

“…Mature T cell lymphomas (MTCLs) have worse prognosis, and in contrast to B cell lymphomas, there is no universal marker like CD20 with exception of ALK and…”
Get full text

Microbiota diversity in patients with Diffuse Large B‐Cell Lymphoma and Immune‐Privileged Sites Lymphoma by Dlouha, L., Tenglerova, M., Rehakova, J., Brichova, M., Kostovcik, M., Benesova, K., Kverka, M., Heissigerova, J., Svozilkova, P., Ondeckova, I., Senavova, J., Herman, V., Kostovcikova, K., Trneny, M.

Get full text

ANALYSIS OF PATIENTS IN THE FIRST RELAPSE OR PROGRESSION OF T‐CELL LYMPHOMA. REAL WORLD DATA FROM CZECH LYMPHOMA STUDY GROUP REGISTRY (NIHIL) by Janikova, A., Belada, D., Klanova, M., Chloupkova, R., Kopalova, N., Campr, V., Kamaradova, K., Prochazka, V., Benesova, K., Mocikova, H., Duras, J., Trneny, M.

Get full text

BRENTUXIMAB VEDOTIN IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED CD30‐POSITIVE PERIPHERAL T‐CELL LYMPHOMAS: REAL‐WORLD DATA by Klanova, M., Sykorova, A., Janikova, A., Mocikova, H., Duras, J., Prochazka, V., Pukyova, J., Klener, P., Belada, D., Kopalova, N., Benesova, K., Campr, V., Blahovcova, P., Trneny, M.

Get full text

HOW WE ARE SUCCESSFUL IN THERAPY OF T‐CELL LYMPHOMA PATIENTS (≥70 YEARS). REAL‐WORDL ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP REGISTRY (NIHIL) by Janikova, A., Klanova, M., Belada, D., Chloupkova, R., Campr, V., Kamaradova, K., Kopalova, N., Benesova, K., Prochazka, V., Mocikova, H., Duras, J., Trneny, M.

Get full text

The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn’s disease by Kunovsky, L., Kala, Z., Marek, F., Dolina, J., Poredska, K., Kucerova, L., Benesova, K., Mitas, L.

“…Purpose Crohn’s disease (CD) belongs to chronic disorders with unpredictable disease course. The aim of this study was to identify how genetic testing…”
Get full text

PERIPHERAL T‐CELL LYMPHOMAS INVOLVING CENTRAL NERVOUS SYSTEM: A REPORT FROM THE CZECH LYMPHOMA STUDY GROUP REGISTRY by Mocikova, H., Pytlik, R., Benesova, K., Janikova, A., Duras, J., Sykorova, A., Steinerova, K., Prochazka, V., Campr, V., Belada, D., Dlouha, J., Trneny, M.

Get full text

Early recognition and screening consultation: a necessary way to improve early detection and treatment in rheumatology? : Overview of the early recognition and screening consultation models for rheumatic and musculoskeletal diseases in Germany by Benesova, K, Lorenz, H-M, Lion, V, Voigt, A, Krause, A, Sander, O, Schneider, M, Feuchtenberger, M, Nigg, A, Leipe, J, Briem, S, Tiessen, E, Haas, F, Rihl, M, Meyer-Olson, D, Baraliakos, X, Braun, J, Schwarting, A, Dreher, M, Witte, T, Assmann, G, Hoeper, K, Schmidt, R E, Bartz-Bazzanella, P, Gaubitz, M, Specker, C

“…In order to reduce the prognostically relevant time interval between the initial manifestation of a rheumatic and musculoskeletal disease and diagnosis as well…”
Get full text

EXTRANODAL NATURAL KILLER (NK)/T‐CELL LYMPHOMA, NASAL TYPE – CASE REPORT AND REVIEW OF CZECH LYMPHOMA STUDY GROUP (CLSG) DATABASE by Steinerova, K., Jindra, P., Lysak, D., Karas, M., Trneny, M., Klener, P., Sykorova, A., Belada, D., Janikova, A., Pytlik, R., Prochazka, V., Benesova, K., Blahovcova, P.

Get full text

T‐CELL LYMPHOMA IN THE ELDERLY PATIENTS. WHO IS YOUNG, OLD, AND ELDERLY? by Janikova, A., Chloupkova, R., Klener, P., Benesova, K., Campr, V., Belada, D., Sykorova, A., Prochazka, V., Kopalova, N., Hamouzova, J., Pirnos, J., Duras, J., Mocikova, H., Trneny, M.

Get full text

PROGNOSTIC VALUE OF THE INTERVAL BETWEEN RELAPSE AND THERAPY INITIATION IN DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS. ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP DATABASE by Janikova, A., Chloupkova, R., Campr, V., Kopalova, N., Klener, P., Benesova, K., Hamouzova, J., Belada, D., Sykorova, A., Prochazka, V., Pirnos, J., Duras, J., Mocikova, H., Michalka, J., Trneny, M.

Get full text

SIMULTANEOUS DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) AND FOLLICULAR LYMPHOMA (FL) AT THE DIAGNOSIS HAS SIMILAR OUTCOME AS DLBCL by Benesova, K., Janikova, A., Belada, D., Prochazka, V., Pytlik, R., Mocikova, H., Sykorova, A., Campr, V., Blahovcova, P., Trneny, M.

Get full text

Chemical Modification of Hyaluronic Acid: Alkylation by Lapčík, L., Benešová, K., Lapčík, L., De Smedt, S., Lapčíková, B.

“…Hydrophobically modified derivatives of hyaluronic acid (HA) are characterized by means of differential scaning calorimetry (DSC) measurements. Simultaneously,…”
Get full text